Luhach, K., Kulkarni, G. T., Singh, V. P., & Sharma, B. (2021). Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats. Clinical & Experimental Pharmacology & Physiology, 48(4), 614. https://doi.org/10.1111/1440-1681.13459
Chicago Style (17th ed.) CitationLuhach, Kanishk, Giriraj T. Kulkarni, Vijay P. Singh, and Bhupesh Sharma. "Effect of Papaverine on Developmental Hyperserotonemia Induced Autism Spectrum Disorder Related Behavioural Phenotypes by Altering Markers of Neuronal Function, Inflammation, and Oxidative Stress in Rats." Clinical & Experimental Pharmacology & Physiology 48, no. 4 (2021): 614. https://doi.org/10.1111/1440-1681.13459.
MLA (9th ed.) CitationLuhach, Kanishk, et al. "Effect of Papaverine on Developmental Hyperserotonemia Induced Autism Spectrum Disorder Related Behavioural Phenotypes by Altering Markers of Neuronal Function, Inflammation, and Oxidative Stress in Rats." Clinical & Experimental Pharmacology & Physiology, vol. 48, no. 4, 2021, p. 614, https://doi.org/10.1111/1440-1681.13459.